Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Planned and completed NCIC CTG trials with BAY...
Conference

Planned and completed NCIC CTG trials with BAY 12-9566, a novel metalloprotease inhibitor (MMPI)

Authors

Seymour L; Hirte H; Goel R; Moore M; Elias I; Kumor K; Humphrey R

Volume

9

Pagination

pp. 76-76

Publisher

KLUWER ACADEMIC PUBL

Publication Date

1998

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534